Market revenue in 2023 | USD 61.6 million |
Market revenue in 2030 | USD 111.9 million |
Growth rate | 8.9% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 32.47% in 2023. Horizon Databook has segmented the Saudi Arabia genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
Extensive research studies involving sequencing can help expand the usage rate of advanced DNA sequencing techniques in this country. A research study published in July 2020 represented the draft genome sequence of AY1MRC from the Mycobacterium tuberculosis strain with the help of WGS technology.
On the other hand, a research study published in April 2020 involved the application of WES as well as systems biology analysis for the identification of CPED1 genetic variant as a putative causative gene to celiac disease. Such research studies are anticipated to supplement the growth of the genomics market in Saudi Arabia.
As reported in July 2020, researchers from King Faisal Specialist Hospital and Research Center conducted exome sequencing on male volunteers to determine that genomic analyses are required for the identification of male infertility, especially for monogenic form. This is one of the largest genomic studies pertaining to male infertility, which expanded the use of exome sequencing in this country.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia genomics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account